ELYRIA, Ohio–(BUSINESS WIRE)–Invacare (NYSE: IVC) today announced that Doug Newlin, Senior Vice President of Global Engineering, will assume leadership of the Company’s regulatory team in place of Colleen Craven, Chief Compliance Officer, who has resigned for personal reasons.
Newlin has experience working with the Food & Drug Administration from his time at Fenwal, Inc., a medical device company and former division of Baxter International Inc. In his role there as Senior Vice President of Research and Development, his functional responsibilities included regulatory and medical affairs.
“We are fortunate that Doug’s experience allows him to step into this role, while we are actively recruiting for Colleen’s replacement. Invacare has many important initiatives underway to enhance its corporate compliance procedures, and we will continue to add resources and expertise to our regulatory affairs and compliance functions,” said Gerald B. Blouch, President and Chief Executive Officer.
Invacare (NYSE:IVC), headquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term care medical products that promote recovery and active lifestyles. The Company has 6,300 associates and markets its products in 80 countries around the world. The Company was named to the 2010 Fortune 1000 list and to the 2010 IndustryWeek U.S. Manufacturing 500. For more information about the Company and its products, visit Invacare’s website at www.invacare.com.
Contact:
Invacare
Lara Mahoney, 440-329-6393